Cresco Labs Inc. ( CRLBF) - Key Metrics
CRLBF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.47 | $0.05 | $0.04 | $0.02 |
| 2026Q1 | $0.41 | -$0.04 | -$0.02 | -$0.04 |
| 2025Q4 | $0.48 | -$0.27 | $0.08 | $0.05 |
| 2025Q3 | $0.46 | -$0.05 | $0.02 | $0 |
| 2025Q2 | $0.46 | -$0.05 | $0.02 | -$0.01 |
CRLBF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 4.15 |
| 2026Q1 | 0% | -6.26 |
| 2025Q4 | 0% | -1.14 |
| 2025Q3 | 0% | -6.95 |
| 2025Q2 | 0% | -2.79 |
CRLBF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.92% | 0% |
| 2026Q1 | -4.05% | 0% |
| 2025Q4 | 4.47% | 0% |
| 2025Q3 | -0.30% | 0% |
| 2025Q2 | -2.45% | 0% |
CRLBF
Price: $0.65
52 week price:
Earnings Per Share: -0.15 USD
P/E Ratio: -6.20
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 276.3 million